The company was bought from a consortium Rabo Capital, Van Lanschot Participaties and Oftavinci.
DORC’s product range includes high precision disposable and re-usable instruments, surgical liquids and surgical machinery that is used for vitreoretinal and cataract procedures.
Its customers include surgical centres, hospitals and physicians across the US, Europe, the mid-East, Asia and South America.
The company generated sales of more than €80m last year.
Montagu investment director Hubert van Wolfswinkel said, “The company is well established in its niche and has an excellent reputation for innovative, high quality products.
“Montagu was impressed by the company’s long term history of growth and track record of continually gaining market share. We believe the company is ideally positioned to continue its impressive growth trajectory.”
Copyright © 2014 AltAssets